These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33175137)

  • 1. COVID-19 and myositis - unique challenges for patients.
    Gupta L; Lilleker JB; Agarwal V; Chinoy H; Aggarwal R
    Rheumatology (Oxford); 2021 Feb; 60(2):907-910. PubMed ID: 33175137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Perspectives on the Effect of the SARS-CoV-2 Pandemic on Patients With Systemic Sclerosis: An International Patient Survey.
    Gupta L; Kharbanda R; Agarwal V; Misra DP; Agarwal V
    J Clin Rheumatol; 2021 Jan; 27(1):31-33. PubMed ID: 33347032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Not Available].
    Wiendl H
    Drug Res (Stuttg); 2015 Nov; 65 Suppl 1():S20. PubMed ID: 26536184
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic inflammatory myopathies.
    Dimachkie MM; Barohn RJ
    Front Neurol Neurosci; 2009; 26():126-146. PubMed ID: 19349710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic.
    Naveen R; Sundaram TG; Agarwal V; Gupta L
    Rheumatol Int; 2021 Jan; 41(1):67-76. PubMed ID: 33150493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of inflammatory myopathies.
    Pipitone N; Salvarani C
    Expert Rev Clin Immunol; 2018 Jul; 14(7):607-621. PubMed ID: 29952659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
    Dalakas MC
    Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies.
    de Salles Painelli V; Gualano B; Artioli GG; de Sá Pinto AL; Bonfá E; Lancha Junior AH; Lima FR
    Autoimmun Rev; 2009 Mar; 8(5):355-9. PubMed ID: 19041955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease.
    Dalakas MC
    J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis.
    Dalakas MC
    Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Idiopathic Inflammatory Myopathies].
    Tomaras S; Kekow J; Feist E
    Dtsch Med Wochenschr; 2020 Jul; 145(13):903-910. PubMed ID: 32615605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory myopathies: evaluation and management.
    Greenberg SA
    Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and Myositis: What We Know So Far.
    Saud A; Naveen R; Aggarwal R; Gupta L
    Curr Rheumatol Rep; 2021 Jul; 23(8):63. PubMed ID: 34216297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: Results of a quality improvement survey.
    Smith M; Nakamoto M; Crocker J; Tiffany Morden F; Liu K; Ma E; Chong A; Van N; Vajjala V; Carrazana E; Viereck J; Liow K
    Headache; 2021 Jan; 61(1):149-156. PubMed ID: 33316097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications.
    Dalakas MC
    Acta Myol; 2020 Dec; 39(4):289-301. PubMed ID: 33458584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory muscle disease - An update.
    Baig S; Paik JJ
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of SARS-CoV-2 on the clinical presentation of juvenile idiopathic inflammatory myopathies.
    Perfetto J; Yoo DA; Tamashiro CY; Perron MM; Vasquez-Canizares N; Wahezi DM
    Pediatr Rheumatol Online J; 2023 Aug; 21(1):82. PubMed ID: 37568191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.